Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Malaria, Cerebral | 27 | 2022 | 136 | 5.670 |
Why?
|
Pathology | 10 | 2022 | 270 | 2.450 |
Why?
|
Plasmodium falciparum | 29 | 2023 | 1742 | 2.280 |
Why?
|
Malaria, Falciparum | 20 | 2023 | 1076 | 1.760 |
Why?
|
Laboratories | 6 | 2024 | 462 | 1.570 |
Why?
|
Pathology, Clinical | 3 | 2024 | 375 | 1.180 |
Why?
|
Malaria | 9 | 2021 | 1226 | 1.140 |
Why?
|
Capacity Building | 6 | 2021 | 257 | 1.050 |
Why?
|
Developing Countries | 11 | 2022 | 2868 | 0.950 |
Why?
|
Neoplasms | 21 | 2024 | 22072 | 0.940 |
Why?
|
Plasmodium | 3 | 2018 | 247 | 0.900 |
Why?
|
Malawi | 22 | 2018 | 301 | 0.890 |
Why?
|
Pathology, Molecular | 8 | 2022 | 329 | 0.800 |
Why?
|
Mycobacterium Infections | 3 | 2017 | 121 | 0.750 |
Why?
|
Parasitemia | 6 | 2015 | 166 | 0.670 |
Why?
|
Immunocompromised Host | 8 | 2015 | 857 | 0.660 |
Why?
|
Clinical Laboratory Techniques | 2 | 2020 | 749 | 0.560 |
Why?
|
Mycoses | 3 | 2014 | 387 | 0.520 |
Why?
|
Microsporidiosis | 1 | 2015 | 23 | 0.500 |
Why?
|
Altruism | 1 | 2017 | 205 | 0.500 |
Why?
|
Parasites | 2 | 2021 | 161 | 0.500 |
Why?
|
Communicable Diseases, Emerging | 1 | 2016 | 150 | 0.490 |
Why?
|
Virus Diseases | 2 | 2021 | 720 | 0.490 |
Why?
|
Spleen | 3 | 2016 | 2298 | 0.480 |
Why?
|
DNA, Protozoan | 3 | 2012 | 228 | 0.470 |
Why?
|
Statistics as Topic | 1 | 2021 | 2362 | 0.470 |
Why?
|
Accreditation | 1 | 2017 | 477 | 0.470 |
Why?
|
Biodiversity | 1 | 2016 | 345 | 0.450 |
Why?
|
Hematologic Diseases | 1 | 2017 | 496 | 0.450 |
Why?
|
Autopsy | 4 | 2022 | 1007 | 0.430 |
Why?
|
Histocytochemistry | 2 | 2014 | 700 | 0.430 |
Why?
|
Dermatofibrosarcoma | 1 | 2012 | 48 | 0.410 |
Why?
|
Erythrocytes | 13 | 2022 | 2415 | 0.400 |
Why?
|
Frontal Lobe | 2 | 2012 | 1420 | 0.400 |
Why?
|
Lung Diseases | 1 | 2022 | 1915 | 0.400 |
Why?
|
Histoplasma | 1 | 2011 | 39 | 0.390 |
Why?
|
Histoplasmosis | 1 | 2011 | 63 | 0.380 |
Why?
|
Africa | 6 | 2023 | 705 | 0.360 |
Why?
|
Humans | 141 | 2024 | 760621 | 0.360 |
Why?
|
Immunohistochemistry | 10 | 2022 | 11071 | 0.340 |
Why?
|
Communicable Diseases | 3 | 2017 | 878 | 0.330 |
Why?
|
Brain | 17 | 2022 | 26951 | 0.330 |
Why?
|
Feces | 2 | 2015 | 1455 | 0.320 |
Why?
|
Adrenal Glands | 1 | 2011 | 554 | 0.320 |
Why?
|
HIV Infections | 15 | 2024 | 17165 | 0.320 |
Why?
|
Medically Underserved Area | 2 | 2014 | 257 | 0.320 |
Why?
|
Organizations | 2 | 2021 | 171 | 0.320 |
Why?
|
Bacterial Infections | 1 | 2017 | 1403 | 0.310 |
Why?
|
Rwanda | 9 | 2022 | 659 | 0.310 |
Why?
|
Medical Oncology | 1 | 2020 | 2313 | 0.310 |
Why?
|
Pregnancy Complications, Parasitic | 1 | 2008 | 61 | 0.310 |
Why?
|
International Cooperation | 3 | 2020 | 1433 | 0.300 |
Why?
|
Antimalarials | 5 | 2023 | 906 | 0.300 |
Why?
|
Uveitis | 1 | 2011 | 393 | 0.300 |
Why?
|
Cities | 2 | 2021 | 538 | 0.290 |
Why?
|
Brain Diseases | 2 | 2018 | 1540 | 0.290 |
Why?
|
Plasmodium berghei | 3 | 2019 | 159 | 0.280 |
Why?
|
Protozoan Proteins | 6 | 2018 | 839 | 0.260 |
Why?
|
Child | 34 | 2022 | 79806 | 0.260 |
Why?
|
Gastrointestinal Diseases | 1 | 2014 | 1190 | 0.260 |
Why?
|
Brain Edema | 2 | 2022 | 603 | 0.240 |
Why?
|
Child, Preschool | 24 | 2021 | 42063 | 0.230 |
Why?
|
Fusobacterium nucleatum | 2 | 2015 | 165 | 0.230 |
Why?
|
Cooperative Behavior | 2 | 2017 | 1500 | 0.230 |
Why?
|
Fever | 1 | 2011 | 1617 | 0.230 |
Why?
|
Lung | 4 | 2022 | 9994 | 0.210 |
Why?
|
Antigens, Protozoan | 3 | 2017 | 316 | 0.210 |
Why?
|
Life Cycle Stages | 2 | 2014 | 160 | 0.210 |
Why?
|
Bone Marrow | 3 | 2018 | 2912 | 0.210 |
Why?
|
Quality Improvement | 1 | 2017 | 3836 | 0.200 |
Why?
|
Paraguay | 1 | 2021 | 7 | 0.200 |
Why?
|
Myanmar | 1 | 2021 | 44 | 0.190 |
Why?
|
Gene Expression Profiling | 3 | 2017 | 9411 | 0.190 |
Why?
|
Genome, Protozoan | 2 | 2016 | 148 | 0.190 |
Why?
|
Gram-Positive Bacterial Infections | 2 | 2015 | 343 | 0.190 |
Why?
|
Antigens, CD | 4 | 2017 | 4000 | 0.190 |
Why?
|
Pneumonia, Bacterial | 2 | 2021 | 319 | 0.180 |
Why?
|
Biopsy, Needle | 3 | 2012 | 1630 | 0.180 |
Why?
|
Brain Abscess | 2 | 2012 | 120 | 0.180 |
Why?
|
Biopsy | 6 | 2022 | 6771 | 0.180 |
Why?
|
Health Services Needs and Demand | 2 | 2019 | 1399 | 0.180 |
Why?
|
Telepathology | 2 | 2018 | 77 | 0.180 |
Why?
|
Haiti | 3 | 2017 | 549 | 0.180 |
Why?
|
Colombia | 1 | 2021 | 276 | 0.180 |
Why?
|
RNA, Viral | 6 | 2021 | 2838 | 0.170 |
Why?
|
Epidemiology | 2 | 2012 | 278 | 0.170 |
Why?
|
World Health Organization | 3 | 2020 | 1312 | 0.170 |
Why?
|
Molecular Diagnostic Techniques | 2 | 2017 | 611 | 0.170 |
Why?
|
Models, Educational | 2 | 2012 | 373 | 0.170 |
Why?
|
Partnership Practice | 1 | 2019 | 14 | 0.170 |
Why?
|
Public Health | 4 | 2020 | 2653 | 0.170 |
Why?
|
Retinal Diseases | 2 | 2018 | 702 | 0.160 |
Why?
|
Atherosclerosis | 1 | 2015 | 3517 | 0.160 |
Why?
|
Candidiasis | 2 | 2011 | 363 | 0.160 |
Why?
|
Regional Health Planning | 1 | 2019 | 96 | 0.160 |
Why?
|
Gene Expression Regulation | 3 | 2014 | 11903 | 0.160 |
Why?
|
Gastrointestinal Tract | 2 | 2015 | 830 | 0.160 |
Why?
|
Macrophages | 1 | 2013 | 5745 | 0.160 |
Why?
|
Candida albicans | 2 | 2011 | 374 | 0.160 |
Why?
|
Genetic Variation | 6 | 2016 | 6551 | 0.150 |
Why?
|
Plasmodium vivax | 2 | 2018 | 202 | 0.150 |
Why?
|
Laboratory Proficiency Testing | 1 | 2017 | 20 | 0.150 |
Why?
|
Africa South of the Sahara | 2 | 2019 | 742 | 0.150 |
Why?
|
Lectins, C-Type | 2 | 2011 | 587 | 0.150 |
Why?
|
Lung Neoplasms | 1 | 2022 | 13262 | 0.150 |
Why?
|
Molecular Epidemiology | 2 | 2018 | 469 | 0.150 |
Why?
|
Placenta | 4 | 2018 | 1702 | 0.150 |
Why?
|
Polymerase Chain Reaction | 5 | 2016 | 6068 | 0.150 |
Why?
|
Penile Neoplasms | 1 | 2019 | 162 | 0.150 |
Why?
|
Transendothelial and Transepithelial Migration | 1 | 2018 | 102 | 0.150 |
Why?
|
Infant | 16 | 2018 | 36060 | 0.150 |
Why?
|
Female | 50 | 2023 | 391270 | 0.140 |
Why?
|
Male | 48 | 2023 | 359744 | 0.140 |
Why?
|
Receptors, Immunologic | 3 | 2012 | 1411 | 0.140 |
Why?
|
Diagnostic Techniques and Procedures | 1 | 2019 | 220 | 0.140 |
Why?
|
Infectious Disease Transmission, Vertical | 3 | 2012 | 1348 | 0.140 |
Why?
|
Tropical Medicine | 1 | 2017 | 51 | 0.140 |
Why?
|
Vietnam | 1 | 2017 | 411 | 0.140 |
Why?
|
Microscopy | 1 | 2022 | 885 | 0.140 |
Why?
|
Macula Lutea | 1 | 2018 | 169 | 0.140 |
Why?
|
Blood Transfusion | 1 | 2023 | 1328 | 0.140 |
Why?
|
Interdisciplinary Communication | 2 | 2012 | 934 | 0.140 |
Why?
|
Government Programs | 1 | 2018 | 280 | 0.130 |
Why?
|
Internationality | 1 | 2022 | 1004 | 0.130 |
Why?
|
Malaria Vaccines | 1 | 2017 | 164 | 0.130 |
Why?
|
Babesia microti | 1 | 2016 | 31 | 0.130 |
Why?
|
Health Priorities | 1 | 2019 | 374 | 0.130 |
Why?
|
Malaria, Vivax | 1 | 2018 | 167 | 0.130 |
Why?
|
Herpesvirus 4, Human | 1 | 2021 | 1075 | 0.130 |
Why?
|
Capillaries | 2 | 2022 | 744 | 0.130 |
Why?
|
Bacillus cereus | 1 | 2015 | 36 | 0.130 |
Why?
|
Microsporidia | 1 | 2015 | 6 | 0.130 |
Why?
|
Lymphoma, Non-Hodgkin | 1 | 2023 | 1375 | 0.130 |
Why?
|
Tamoxifen | 1 | 2020 | 963 | 0.130 |
Why?
|
Health Personnel | 3 | 2018 | 3310 | 0.130 |
Why?
|
Fusarium | 1 | 2015 | 51 | 0.130 |
Why?
|
Anus Neoplasms | 1 | 2019 | 329 | 0.130 |
Why?
|
Tissue Array Analysis | 2 | 2015 | 551 | 0.130 |
Why?
|
Pneumonia | 3 | 2017 | 2131 | 0.120 |
Why?
|
Conservation of Natural Resources | 1 | 2017 | 211 | 0.120 |
Why?
|
Babesiosis | 1 | 2016 | 92 | 0.120 |
Why?
|
Biostatistics | 1 | 2016 | 164 | 0.120 |
Why?
|
Nigeria | 3 | 2015 | 762 | 0.120 |
Why?
|
Meningoencephalitis | 1 | 2015 | 83 | 0.120 |
Why?
|
Measles virus | 1 | 2015 | 67 | 0.120 |
Why?
|
Breast Neoplasms | 5 | 2023 | 21025 | 0.120 |
Why?
|
Biomedical Research | 3 | 2020 | 3426 | 0.120 |
Why?
|
HIV-1 | 8 | 2017 | 6849 | 0.120 |
Why?
|
Uterine Cervical Neoplasms | 3 | 2023 | 2003 | 0.120 |
Why?
|
Lassa virus | 1 | 2015 | 99 | 0.120 |
Why?
|
United States | 12 | 2021 | 72461 | 0.120 |
Why?
|
Urogenital System | 1 | 2014 | 88 | 0.120 |
Why?
|
Lassa Fever | 1 | 2015 | 97 | 0.120 |
Why?
|
Endocrine Glands | 1 | 2014 | 101 | 0.120 |
Why?
|
Mycobacterium avium-intracellulare Infection | 1 | 2014 | 76 | 0.120 |
Why?
|
Virulence Factors | 1 | 2018 | 511 | 0.110 |
Why?
|
Pregnancy Complications, Infectious | 4 | 2013 | 2125 | 0.110 |
Why?
|
Thrombin | 1 | 2016 | 593 | 0.110 |
Why?
|
Genital Neoplasms, Female | 1 | 2019 | 533 | 0.110 |
Why?
|
Pulmonary Aspergillosis | 1 | 2014 | 47 | 0.110 |
Why?
|
Opportunistic Infections | 2 | 2014 | 377 | 0.110 |
Why?
|
Carcinoma | 2 | 2015 | 2331 | 0.110 |
Why?
|
Melioidosis | 1 | 2013 | 11 | 0.110 |
Why?
|
Peritonitis, Tuberculous | 1 | 2013 | 6 | 0.110 |
Why?
|
Species Specificity | 1 | 2018 | 2418 | 0.110 |
Why?
|
Antigens, Surface | 1 | 2017 | 1608 | 0.110 |
Why?
|
Genotype | 9 | 2019 | 12960 | 0.110 |
Why?
|
Host-Pathogen Interactions | 3 | 2016 | 1447 | 0.110 |
Why?
|
Epigenomics | 2 | 2016 | 936 | 0.110 |
Why?
|
Hepatitis C | 1 | 2023 | 1579 | 0.110 |
Why?
|
Income | 1 | 2022 | 1875 | 0.110 |
Why?
|
Papillomaviridae | 1 | 2019 | 1117 | 0.110 |
Why?
|
Skin | 4 | 2015 | 4466 | 0.110 |
Why?
|
Skin Neoplasms | 1 | 2012 | 5799 | 0.110 |
Why?
|
Drug Resistance | 2 | 2011 | 1617 | 0.110 |
Why?
|
Adenoviruses, Human | 1 | 2014 | 255 | 0.100 |
Why?
|
Disease Models, Animal | 5 | 2018 | 18137 | 0.100 |
Why?
|
Cytochromes b | 2 | 2016 | 34 | 0.100 |
Why?
|
Measles | 1 | 2015 | 185 | 0.100 |
Why?
|
Trophozoites | 1 | 2012 | 13 | 0.100 |
Why?
|
Urban Population | 2 | 2019 | 2022 | 0.100 |
Why?
|
Lymphoma | 1 | 2021 | 1898 | 0.100 |
Why?
|
Schizonts | 1 | 2012 | 22 | 0.100 |
Why?
|
Retinal Vessels | 1 | 2018 | 836 | 0.100 |
Why?
|
Granuloma | 1 | 2014 | 327 | 0.100 |
Why?
|
Encephalitis, Viral | 1 | 2012 | 59 | 0.100 |
Why?
|
CD8-Positive T-Lymphocytes | 2 | 2019 | 4550 | 0.100 |
Why?
|
Fetal Proteins | 1 | 2012 | 97 | 0.100 |
Why?
|
Diagnosis-Related Groups | 1 | 2013 | 450 | 0.100 |
Why?
|
Proto-Oncogene Proteins c-vav | 1 | 2011 | 91 | 0.100 |
Why?
|
Arthritis, Infectious | 1 | 2015 | 345 | 0.100 |
Why?
|
Diagnostic Tests, Routine | 1 | 2017 | 786 | 0.100 |
Why?
|
HIV-2 | 1 | 2012 | 156 | 0.100 |
Why?
|
Histological Techniques | 1 | 2012 | 194 | 0.100 |
Why?
|
Genome, Viral | 1 | 2015 | 658 | 0.100 |
Why?
|
Animals | 27 | 2021 | 167963 | 0.100 |
Why?
|
Mycology | 1 | 2011 | 13 | 0.100 |
Why?
|
Molecular Typing | 1 | 2012 | 116 | 0.100 |
Why?
|
Colorectal Neoplasms | 3 | 2015 | 6853 | 0.100 |
Why?
|
Climate Change | 1 | 2017 | 488 | 0.090 |
Why?
|
Selection, Genetic | 3 | 2013 | 869 | 0.090 |
Why?
|
Pneumonia, Viral | 2 | 2021 | 3205 | 0.090 |
Why?
|
Mucorales | 1 | 2011 | 35 | 0.090 |
Why?
|
Immunity, Mucosal | 1 | 2014 | 482 | 0.090 |
Why?
|
Health Services Accessibility | 2 | 2024 | 5397 | 0.090 |
Why?
|
Macrophage-1 Antigen | 1 | 2011 | 286 | 0.090 |
Why?
|
Host-Parasite Interactions | 2 | 2018 | 301 | 0.090 |
Why?
|
Rural Health Services | 1 | 2014 | 381 | 0.090 |
Why?
|
Eligibility Determination | 1 | 2014 | 421 | 0.090 |
Why?
|
Pathology, Surgical | 1 | 2012 | 151 | 0.090 |
Why?
|
Micrococcaceae | 1 | 2010 | 8 | 0.090 |
Why?
|
Lymphadenitis | 1 | 2011 | 98 | 0.090 |
Why?
|
Program Evaluation | 1 | 2019 | 2493 | 0.090 |
Why?
|
Ascomycota | 1 | 2011 | 81 | 0.090 |
Why?
|
Adaptive Immunity | 1 | 2015 | 726 | 0.090 |
Why?
|
Geotrichosis | 1 | 2009 | 2 | 0.090 |
Why?
|
Genetics, Population | 1 | 2015 | 930 | 0.090 |
Why?
|
Geotrichum | 1 | 2009 | 4 | 0.090 |
Why?
|
Cytomegalovirus | 1 | 2014 | 755 | 0.090 |
Why?
|
Leukemia, Myeloid, Acute | 5 | 2015 | 3602 | 0.090 |
Why?
|
Cytological Techniques | 1 | 2012 | 218 | 0.090 |
Why?
|
Incidence | 3 | 2019 | 21392 | 0.090 |
Why?
|
Mucormycosis | 1 | 2011 | 103 | 0.090 |
Why?
|
Polymorphism, Single Nucleotide | 7 | 2012 | 15789 | 0.090 |
Why?
|
RNA, Messenger | 2 | 2022 | 12766 | 0.090 |
Why?
|
Cell Adhesion | 1 | 2016 | 3094 | 0.090 |
Why?
|
Schools | 1 | 2018 | 1480 | 0.080 |
Why?
|
Chemokines | 2 | 2012 | 962 | 0.080 |
Why?
|
Periodicals as Topic | 1 | 2021 | 1469 | 0.080 |
Why?
|
Sensitivity and Specificity | 6 | 2018 | 14660 | 0.080 |
Why?
|
Staining and Labeling | 1 | 2014 | 1089 | 0.080 |
Why?
|
Fetal Blood | 2 | 2014 | 1343 | 0.080 |
Why?
|
Scalp | 1 | 2012 | 389 | 0.080 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 1 | 2015 | 1088 | 0.080 |
Why?
|
Blood | 1 | 2012 | 586 | 0.080 |
Why?
|
Nutritional Status | 1 | 2017 | 1607 | 0.080 |
Why?
|
Transplantation | 1 | 2011 | 218 | 0.080 |
Why?
|
Abscess | 2 | 2013 | 605 | 0.080 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2022 | 3340 | 0.080 |
Why?
|
Antigens, Differentiation | 1 | 2012 | 911 | 0.080 |
Why?
|
Eye Diseases | 1 | 2014 | 651 | 0.080 |
Why?
|
Anti-HIV Agents | 3 | 2014 | 4491 | 0.080 |
Why?
|
Myasthenia Gravis | 1 | 2011 | 213 | 0.080 |
Why?
|
Retina | 2 | 2022 | 2635 | 0.080 |
Why?
|
Faculty, Medical | 1 | 2017 | 1192 | 0.080 |
Why?
|
Education, Medical, Graduate | 2 | 2020 | 2363 | 0.080 |
Why?
|
DNA Fingerprinting | 1 | 2008 | 111 | 0.080 |
Why?
|
Fellowships and Scholarships | 1 | 2017 | 1116 | 0.080 |
Why?
|
Middle Aged | 21 | 2021 | 220352 | 0.080 |
Why?
|
Rural Health | 1 | 2010 | 296 | 0.080 |
Why?
|
Dermatitis | 1 | 2010 | 200 | 0.080 |
Why?
|
Vaccines | 1 | 2017 | 832 | 0.080 |
Why?
|
AIDS Vaccines | 1 | 2014 | 895 | 0.080 |
Why?
|
Skin Diseases, Bacterial | 1 | 2008 | 68 | 0.070 |
Why?
|
Cytomegalovirus Infections | 1 | 2014 | 831 | 0.070 |
Why?
|
Amino Acid Substitution | 2 | 2016 | 1737 | 0.070 |
Why?
|
Treponema pallidum | 2 | 2023 | 47 | 0.070 |
Why?
|
Blood Vessels | 1 | 2013 | 1112 | 0.070 |
Why?
|
Early Detection of Cancer | 1 | 2022 | 3202 | 0.070 |
Why?
|
Papillomavirus Infections | 1 | 2019 | 1607 | 0.070 |
Why?
|
Research Design | 2 | 2021 | 6180 | 0.070 |
Why?
|
Pregnancy | 7 | 2018 | 29749 | 0.070 |
Why?
|
Encephalitis | 1 | 2011 | 437 | 0.070 |
Why?
|
Proguanil | 1 | 2006 | 11 | 0.070 |
Why?
|
Blood Coagulation | 1 | 2013 | 1157 | 0.070 |
Why?
|
Diagnosis, Differential | 4 | 2016 | 12965 | 0.070 |
Why?
|
Adult | 19 | 2021 | 219994 | 0.070 |
Why?
|
Receptors, Cell Surface | 2 | 2013 | 2825 | 0.070 |
Why?
|
History, 21st Century | 1 | 2013 | 1575 | 0.070 |
Why?
|
Naphthoquinones | 1 | 2006 | 60 | 0.070 |
Why?
|
Tumor Burden | 1 | 2012 | 1895 | 0.070 |
Why?
|
Curriculum | 1 | 2020 | 3718 | 0.070 |
Why?
|
Cadherins | 1 | 2011 | 898 | 0.070 |
Why?
|
Face | 1 | 2012 | 1017 | 0.070 |
Why?
|
Cross Infection | 1 | 2015 | 1434 | 0.070 |
Why?
|
Senegal | 3 | 2015 | 256 | 0.070 |
Why?
|
Monocytes | 1 | 2015 | 2575 | 0.070 |
Why?
|
Disease Transmission, Infectious | 1 | 2011 | 558 | 0.070 |
Why?
|
Microarray Analysis | 1 | 2008 | 747 | 0.060 |
Why?
|
Strongyloides stercoralis | 1 | 2005 | 23 | 0.060 |
Why?
|
Practice Guidelines as Topic | 2 | 2020 | 7475 | 0.060 |
Why?
|
CD4 Lymphocyte Count | 4 | 2014 | 2569 | 0.060 |
Why?
|
Strongyloidiasis | 1 | 2005 | 27 | 0.060 |
Why?
|
Databases, Genetic | 1 | 2012 | 1738 | 0.060 |
Why?
|
Ivermectin | 1 | 2005 | 46 | 0.060 |
Why?
|
Antiparasitic Agents | 1 | 2005 | 43 | 0.060 |
Why?
|
Case-Control Studies | 5 | 2015 | 22053 | 0.060 |
Why?
|
L-Lactate Dehydrogenase | 1 | 2006 | 412 | 0.060 |
Why?
|
Communicable Disease Control | 1 | 2011 | 844 | 0.060 |
Why?
|
Reproducibility of Results | 2 | 2021 | 20080 | 0.060 |
Why?
|
Cluster Analysis | 1 | 2012 | 2698 | 0.060 |
Why?
|
Zoonoses | 2 | 2016 | 179 | 0.060 |
Why?
|
History, 20th Century | 1 | 2013 | 2773 | 0.060 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2012 | 1652 | 0.060 |
Why?
|
Community Health Services | 1 | 2010 | 654 | 0.060 |
Why?
|
Blood Platelets | 1 | 2015 | 2520 | 0.060 |
Why?
|
Blood-Brain Barrier | 1 | 2011 | 1019 | 0.060 |
Why?
|
Referral and Consultation | 1 | 2017 | 3598 | 0.060 |
Why?
|
Fatigue | 1 | 2011 | 1544 | 0.060 |
Why?
|
Neoplasm Invasiveness | 1 | 2012 | 3618 | 0.060 |
Why?
|
Leishmaniasis, Mucocutaneous | 1 | 2003 | 14 | 0.060 |
Why?
|
Prevalence | 3 | 2019 | 15687 | 0.060 |
Why?
|
Viral Load | 5 | 2012 | 3322 | 0.060 |
Why?
|
Gingival Diseases | 1 | 2003 | 36 | 0.060 |
Why?
|
Syphilis | 1 | 2006 | 241 | 0.060 |
Why?
|
Severity of Illness Index | 3 | 2019 | 15840 | 0.060 |
Why?
|
Africa, Western | 2 | 2015 | 159 | 0.060 |
Why?
|
Drugs, Essential | 1 | 2024 | 70 | 0.060 |
Why?
|
Gene Expression | 2 | 2013 | 7588 | 0.060 |
Why?
|
Internship and Residency | 3 | 2020 | 5870 | 0.050 |
Why?
|
Adolescent | 11 | 2021 | 87810 | 0.050 |
Why?
|
Palate | 1 | 2003 | 124 | 0.050 |
Why?
|
Zambia | 1 | 2024 | 257 | 0.050 |
Why?
|
Bacteremia | 1 | 2010 | 980 | 0.050 |
Why?
|
Oral Ulcer | 1 | 2003 | 96 | 0.050 |
Why?
|
Risk | 1 | 2015 | 9631 | 0.050 |
Why?
|
Blood Banks | 1 | 2023 | 108 | 0.050 |
Why?
|
Shock, Septic | 1 | 2009 | 761 | 0.050 |
Why?
|
Quality of Health Care | 1 | 2018 | 4360 | 0.050 |
Why?
|
Histiocytosis, Langerhans-Cell | 1 | 2004 | 169 | 0.050 |
Why?
|
Glucosamine | 1 | 2022 | 128 | 0.050 |
Why?
|
Atovaquone | 2 | 2016 | 56 | 0.050 |
Why?
|
Alkaline Phosphatase | 1 | 2005 | 865 | 0.050 |
Why?
|
Mannose | 1 | 2022 | 121 | 0.050 |
Why?
|
Coma | 1 | 2006 | 487 | 0.050 |
Why?
|
Cytokines | 3 | 2014 | 7343 | 0.050 |
Why?
|
Tumor Microenvironment | 1 | 2015 | 3844 | 0.050 |
Why?
|
Hemorrhage | 1 | 2014 | 3600 | 0.050 |
Why?
|
Immunotherapy | 1 | 2018 | 4642 | 0.050 |
Why?
|
Retrospective Studies | 8 | 2021 | 80372 | 0.050 |
Why?
|
Delivery of Health Care | 2 | 2017 | 5325 | 0.050 |
Why?
|
Blood-Retinal Barrier | 1 | 2022 | 62 | 0.050 |
Why?
|
N-Acetylneuraminic Acid | 1 | 2022 | 173 | 0.050 |
Why?
|
Microsatellite Instability | 2 | 2015 | 715 | 0.050 |
Why?
|
Ligases | 1 | 2023 | 332 | 0.050 |
Why?
|
Glycocalyx | 1 | 2022 | 94 | 0.050 |
Why?
|
Genetic Loci | 1 | 2011 | 2618 | 0.050 |
Why?
|
Lymphocyte Count | 2 | 2015 | 780 | 0.050 |
Why?
|
Myocardium | 1 | 2014 | 4700 | 0.050 |
Why?
|
Antifungal Agents | 3 | 2011 | 749 | 0.050 |
Why?
|
Neoplasm Staging | 2 | 2015 | 11152 | 0.050 |
Why?
|
Blood Donors | 1 | 2023 | 343 | 0.050 |
Why?
|
Trans-Activators | 1 | 2011 | 2860 | 0.050 |
Why?
|
Aged | 9 | 2015 | 169152 | 0.050 |
Why?
|
Inflammation | 2 | 2013 | 10756 | 0.050 |
Why?
|
Point Mutation | 1 | 2006 | 1594 | 0.050 |
Why?
|
Mozambique | 1 | 2021 | 55 | 0.050 |
Why?
|
Endothelium, Vascular | 1 | 2013 | 4433 | 0.050 |
Why?
|
Stem Cell Transplantation | 1 | 2009 | 1599 | 0.050 |
Why?
|
Transplantation, Homologous | 1 | 2009 | 4810 | 0.050 |
Why?
|
Mice | 7 | 2021 | 81208 | 0.050 |
Why?
|
Sierra Leone | 1 | 2021 | 168 | 0.050 |
Why?
|
Gene Amplification | 1 | 2005 | 1085 | 0.050 |
Why?
|
Lectins | 1 | 2022 | 484 | 0.050 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 3 | 2014 | 3804 | 0.040 |
Why?
|
Young Adult | 6 | 2021 | 58741 | 0.040 |
Why?
|
Adrenal Cortex Hormones | 1 | 2009 | 1869 | 0.040 |
Why?
|
Prostatic Neoplasms | 1 | 2023 | 11345 | 0.040 |
Why?
|
Technology | 1 | 2022 | 291 | 0.040 |
Why?
|
Weight Loss | 1 | 2011 | 2686 | 0.040 |
Why?
|
Fluorescent Antibody Technique | 2 | 2017 | 2471 | 0.040 |
Why?
|
Women's Health Services | 1 | 2020 | 89 | 0.040 |
Why?
|
Genomics | 3 | 2016 | 5794 | 0.040 |
Why?
|
Glycosaminoglycans | 1 | 2022 | 605 | 0.040 |
Why?
|
Exanthema | 1 | 2004 | 504 | 0.040 |
Why?
|
Antibodies, Protozoan | 2 | 2011 | 251 | 0.040 |
Why?
|
Oncogenes | 1 | 2005 | 1220 | 0.040 |
Why?
|
Glioblastoma | 1 | 2014 | 3484 | 0.040 |
Why?
|
Tanzania | 1 | 2023 | 1383 | 0.040 |
Why?
|
Neutrophils | 1 | 2011 | 3767 | 0.040 |
Why?
|
Prospective Studies | 4 | 2022 | 54303 | 0.040 |
Why?
|
Intercellular Adhesion Molecule-1 | 1 | 2022 | 1126 | 0.040 |
Why?
|
Medical Audit | 2 | 2013 | 452 | 0.040 |
Why?
|
Vaginal Neoplasms | 1 | 2019 | 104 | 0.040 |
Why?
|
Mononuclear Phagocyte System | 1 | 2018 | 54 | 0.040 |
Why?
|
Aotidae | 1 | 2018 | 59 | 0.040 |
Why?
|
Chromosome Mapping | 1 | 2006 | 4625 | 0.040 |
Why?
|
Diagnosis | 1 | 2019 | 157 | 0.040 |
Why?
|
Treatment Outcome | 7 | 2014 | 65017 | 0.040 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2012 | 3075 | 0.040 |
Why?
|
Food Chain | 1 | 2017 | 27 | 0.040 |
Why?
|
Wounds and Injuries | 1 | 2011 | 2477 | 0.040 |
Why?
|
T-Lymphocytes | 1 | 2015 | 10181 | 0.040 |
Why?
|
Madagascar | 1 | 2017 | 110 | 0.040 |
Why?
|
Diabetes Mellitus | 1 | 2016 | 5889 | 0.040 |
Why?
|
South Africa | 1 | 2023 | 1821 | 0.040 |
Why?
|
Premature Birth | 2 | 2013 | 1771 | 0.040 |
Why?
|
Chordata, Nonvertebrate | 1 | 1997 | 14 | 0.040 |
Why?
|
Butyrylcholinesterase | 1 | 1997 | 21 | 0.040 |
Why?
|
Saimiri | 1 | 2018 | 334 | 0.040 |
Why?
|
Developed Countries | 1 | 2020 | 442 | 0.040 |
Why?
|
Nuclear Proteins | 1 | 2012 | 5791 | 0.040 |
Why?
|
Mutation, Missense | 1 | 2006 | 2566 | 0.040 |
Why?
|
Heart Transplantation | 1 | 2011 | 3224 | 0.040 |
Why?
|
Financial Management | 1 | 2018 | 161 | 0.040 |
Why?
|
Acetylcholinesterase | 1 | 1997 | 156 | 0.030 |
Why?
|
Vulvar Neoplasms | 1 | 2019 | 263 | 0.030 |
Why?
|
DNA, Bacterial | 2 | 2015 | 1456 | 0.030 |
Why?
|
Magnetic Resonance Imaging | 4 | 2018 | 36290 | 0.030 |
Why?
|
Infant, Newborn | 5 | 2017 | 26181 | 0.030 |
Why?
|
Immunosuppressive Agents | 1 | 2009 | 4166 | 0.030 |
Why?
|
Standard of Care | 1 | 2020 | 552 | 0.030 |
Why?
|
Allergy and Immunology | 1 | 2018 | 175 | 0.030 |
Why?
|
Cell Lineage | 1 | 2005 | 2533 | 0.030 |
Why?
|
Receptors, Interleukin-10 | 1 | 2016 | 49 | 0.030 |
Why?
|
Epitopes | 1 | 2022 | 2503 | 0.030 |
Why?
|
Murinae | 1 | 2015 | 18 | 0.030 |
Why?
|
Ribotyping | 1 | 2015 | 35 | 0.030 |
Why?
|
Problem Solving | 1 | 2018 | 440 | 0.030 |
Why?
|
Observer Variation | 1 | 2022 | 2601 | 0.030 |
Why?
|
Estrogens | 1 | 2022 | 1520 | 0.030 |
Why?
|
Matrix Metalloproteinase 1 | 1 | 2016 | 142 | 0.030 |
Why?
|
Faculty | 1 | 2018 | 383 | 0.030 |
Why?
|
Disease Reservoirs | 1 | 2015 | 121 | 0.030 |
Why?
|
Microscopy, Electron, Transmission | 1 | 2017 | 697 | 0.030 |
Why?
|
Azithromycin | 1 | 2016 | 200 | 0.030 |
Why?
|
Haptoglobins | 1 | 2016 | 167 | 0.030 |
Why?
|
Virology | 1 | 2015 | 74 | 0.030 |
Why?
|
Colon | 2 | 2014 | 1788 | 0.030 |
Why?
|
Follow-Up Studies | 2 | 2015 | 39261 | 0.030 |
Why?
|
Measles Vaccine | 1 | 2015 | 81 | 0.030 |
Why?
|
Rosaniline Dyes | 1 | 2014 | 48 | 0.030 |
Why?
|
Suicide | 1 | 2005 | 1599 | 0.030 |
Why?
|
Viral Tropism | 1 | 2015 | 102 | 0.030 |
Why?
|
Hematopoietic System | 1 | 2014 | 109 | 0.030 |
Why?
|
Cause of Death | 1 | 2005 | 3725 | 0.030 |
Why?
|
Ganciclovir | 1 | 2014 | 252 | 0.030 |
Why?
|
Peer Review, Research | 1 | 2017 | 340 | 0.030 |
Why?
|
Gene Dosage | 2 | 2011 | 1218 | 0.030 |
Why?
|
Ribosomal Proteins | 1 | 2016 | 363 | 0.030 |
Why?
|
Predictive Value of Tests | 3 | 2015 | 15289 | 0.030 |
Why?
|
Receptors, Tumor Necrosis Factor, Type II | 1 | 2016 | 346 | 0.030 |
Why?
|
Obesity | 1 | 2016 | 12922 | 0.030 |
Why?
|
Thienamycins | 1 | 2013 | 29 | 0.030 |
Why?
|
Burkholderia pseudomallei | 1 | 2013 | 9 | 0.030 |
Why?
|
Papilledema | 1 | 2015 | 130 | 0.030 |
Why?
|
National Institutes of Health (U.S.) | 1 | 2017 | 791 | 0.030 |
Why?
|
CD4-Positive T-Lymphocytes | 2 | 2017 | 4353 | 0.030 |
Why?
|
Phylogeny | 3 | 2008 | 2775 | 0.030 |
Why?
|
Proteomics | 2 | 2017 | 3817 | 0.030 |
Why?
|
Brain Neoplasms | 1 | 2014 | 8986 | 0.030 |
Why?
|
Granulomatous Disease, Chronic | 1 | 2014 | 173 | 0.030 |
Why?
|
Injections, Intramuscular | 1 | 2014 | 553 | 0.030 |
Why?
|
Mutation | 4 | 2023 | 29932 | 0.030 |
Why?
|
Cambodia | 1 | 2013 | 186 | 0.030 |
Why?
|
Genes | 1 | 1997 | 1845 | 0.030 |
Why?
|
Leptin | 1 | 2021 | 1591 | 0.030 |
Why?
|
Research Support as Topic | 1 | 2017 | 699 | 0.030 |
Why?
|
Aged, 80 and over | 2 | 2015 | 58995 | 0.030 |
Why?
|
Thrombomodulin | 1 | 2013 | 105 | 0.030 |
Why?
|
Ebolavirus | 1 | 2015 | 251 | 0.030 |
Why?
|
Gadolinium | 1 | 2018 | 959 | 0.030 |
Why?
|
Disease Susceptibility | 1 | 2019 | 1791 | 0.030 |
Why?
|
Angiography | 1 | 2018 | 1605 | 0.030 |
Why?
|
Lactic Acid | 1 | 2018 | 1134 | 0.030 |
Why?
|
Esophageal Neoplasms | 2 | 2013 | 1648 | 0.030 |
Why?
|
Immunoassay | 1 | 2016 | 746 | 0.030 |
Why?
|
Signal Transduction | 2 | 2012 | 23376 | 0.030 |
Why?
|
Propionibacterium acnes | 1 | 2012 | 65 | 0.030 |
Why?
|
Omentum | 1 | 2013 | 169 | 0.030 |
Why?
|
Plasmodium knowlesi | 1 | 2012 | 23 | 0.020 |
Why?
|
Duffy Blood-Group System | 1 | 2012 | 60 | 0.020 |
Why?
|
Schistosomiasis | 1 | 2012 | 64 | 0.020 |
Why?
|
Radiography | 2 | 2014 | 6965 | 0.020 |
Why?
|
Reye Syndrome | 1 | 2011 | 28 | 0.020 |
Why?
|
Mefloquine | 1 | 2011 | 55 | 0.020 |
Why?
|
env Gene Products, Human Immunodeficiency Virus | 1 | 2014 | 368 | 0.020 |
Why?
|
RNA, Ribosomal, 18S | 1 | 2011 | 57 | 0.020 |
Why?
|
Health Education | 1 | 2018 | 1049 | 0.020 |
Why?
|
Comprehension | 1 | 2016 | 618 | 0.020 |
Why?
|
Molecular Imaging | 1 | 2018 | 818 | 0.020 |
Why?
|
Cohort Studies | 4 | 2017 | 41335 | 0.020 |
Why?
|
Cross-Sectional Studies | 3 | 2019 | 25942 | 0.020 |
Why?
|
Class I Phosphatidylinositol 3-Kinases | 1 | 2015 | 895 | 0.020 |
Why?
|
Phenanthrenes | 1 | 2011 | 67 | 0.020 |
Why?
|
Virulence | 1 | 2015 | 1298 | 0.020 |
Why?
|
Flow Cytometry | 2 | 2012 | 5870 | 0.020 |
Why?
|
Fluconazole | 1 | 2011 | 155 | 0.020 |
Why?
|
Recurrence | 2 | 2016 | 8482 | 0.020 |
Why?
|
Risk Assessment | 1 | 2012 | 24123 | 0.020 |
Why?
|
Ethanolamines | 1 | 2011 | 154 | 0.020 |
Why?
|
Image Processing, Computer-Assisted | 2 | 2018 | 8950 | 0.020 |
Why?
|
Foreign Bodies | 1 | 1994 | 397 | 0.020 |
Why?
|
Lymphoid Tissue | 1 | 2012 | 445 | 0.020 |
Why?
|
Ritonavir | 1 | 2012 | 328 | 0.020 |
Why?
|
Actinomycetales Infections | 1 | 2010 | 30 | 0.020 |
Why?
|
Cardiovascular Diseases | 1 | 2016 | 15757 | 0.020 |
Why?
|
Hemorrhagic Fever, Ebola | 1 | 2015 | 420 | 0.020 |
Why?
|
Hospitals | 1 | 2024 | 3928 | 0.020 |
Why?
|
DNA, Ribosomal | 1 | 2011 | 285 | 0.020 |
Why?
|
Fluorenes | 1 | 2011 | 156 | 0.020 |
Why?
|
DNA, Fungal | 1 | 2011 | 275 | 0.020 |
Why?
|
Urinary Bladder Neoplasms | 2 | 2013 | 2276 | 0.020 |
Why?
|
Publishing | 1 | 2017 | 836 | 0.020 |
Why?
|
Organ Size | 1 | 2015 | 2254 | 0.020 |
Why?
|
Forecasting | 1 | 2019 | 2932 | 0.020 |
Why?
|
Fatal Outcome | 1 | 2014 | 1832 | 0.020 |
Why?
|
Biological Evolution | 1 | 2015 | 1074 | 0.020 |
Why?
|
Anopheles | 1 | 2011 | 192 | 0.020 |
Why?
|
Live Birth | 1 | 2013 | 512 | 0.020 |
Why?
|
Primates | 1 | 2012 | 523 | 0.020 |
Why?
|
Point-of-Care Systems | 1 | 2018 | 1204 | 0.020 |
Why?
|
Adipose Tissue | 1 | 2021 | 3301 | 0.020 |
Why?
|
Suppuration | 1 | 2008 | 61 | 0.020 |
Why?
|
Antiretroviral Therapy, Highly Active | 1 | 2017 | 1894 | 0.020 |
Why?
|
Pulmonary Emphysema | 1 | 2014 | 688 | 0.020 |
Why?
|
Sequence Analysis, RNA | 1 | 2017 | 2005 | 0.020 |
Why?
|
Esophagus | 1 | 1994 | 1023 | 0.020 |
Why?
|
Skull | 1 | 2013 | 815 | 0.020 |
Why?
|
Mice, Inbred BALB C | 1 | 2017 | 6216 | 0.020 |
Why?
|
Immunologic Factors | 1 | 2018 | 1588 | 0.020 |
Why?
|
Drug Resistance, Microbial | 1 | 2011 | 856 | 0.020 |
Why?
|
Students | 1 | 2018 | 1730 | 0.020 |
Why?
|
National Health Programs | 1 | 2011 | 441 | 0.020 |
Why?
|
Health Resources | 1 | 2014 | 935 | 0.020 |
Why?
|
Sequence Homology, Amino Acid | 2 | 2006 | 2753 | 0.020 |
Why?
|
Viral Proteins | 1 | 2015 | 1802 | 0.020 |
Why?
|
Cell Membrane | 1 | 2017 | 3682 | 0.020 |
Why?
|
Cervix Uteri | 1 | 2012 | 582 | 0.020 |
Why?
|
RNA, Ribosomal, 16S | 1 | 2012 | 1006 | 0.020 |
Why?
|
DNA-Binding Proteins | 1 | 2005 | 9585 | 0.020 |
Why?
|
Deoxycytidine | 1 | 2012 | 873 | 0.020 |
Why?
|
Glycoproteins | 1 | 2015 | 2208 | 0.020 |
Why?
|
Proteome | 1 | 2017 | 1855 | 0.020 |
Why?
|
HIV Antibodies | 1 | 2014 | 1300 | 0.020 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 2015 | 1728 | 0.020 |
Why?
|
Geography | 1 | 2009 | 661 | 0.020 |
Why?
|
Prognosis | 2 | 2020 | 29658 | 0.020 |
Why?
|
Chronic Disease | 2 | 2012 | 9287 | 0.020 |
Why?
|
Central America | 1 | 2006 | 65 | 0.020 |
Why?
|
Multiple Birth Offspring | 1 | 2006 | 22 | 0.020 |
Why?
|
Metabolomics | 1 | 2016 | 1628 | 0.020 |
Why?
|
Drug Therapy | 1 | 2010 | 504 | 0.020 |
Why?
|
Congresses as Topic | 1 | 2012 | 805 | 0.020 |
Why?
|
Time Factors | 3 | 2021 | 40165 | 0.020 |
Why?
|
DNA Primers | 1 | 2011 | 2819 | 0.020 |
Why?
|
South America | 1 | 2006 | 181 | 0.020 |
Why?
|
Melanoma | 1 | 2005 | 5697 | 0.020 |
Why?
|
Adenine | 1 | 2012 | 975 | 0.020 |
Why?
|
Merozoite Surface Protein 1 | 1 | 2006 | 38 | 0.020 |
Why?
|
Carcinoma in Situ | 1 | 2012 | 796 | 0.020 |
Why?
|
Socioeconomic Factors | 1 | 2020 | 7806 | 0.020 |
Why?
|
Drug Combinations | 1 | 2012 | 2025 | 0.020 |
Why?
|
Mice, Inbred C57BL | 2 | 2017 | 22023 | 0.020 |
Why?
|
Linkage Disequilibrium | 1 | 2011 | 1996 | 0.020 |
Why?
|
Phagocytosis | 1 | 2011 | 1535 | 0.020 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2015 | 2864 | 0.020 |
Why?
|
Down-Regulation | 1 | 2013 | 2913 | 0.020 |
Why?
|
Anemia | 2 | 2006 | 1511 | 0.020 |
Why?
|
Immunity, Cellular | 1 | 2011 | 1557 | 0.020 |
Why?
|
Risk Factors | 3 | 2015 | 74359 | 0.020 |
Why?
|
Seasons | 1 | 2011 | 1522 | 0.020 |
Why?
|
Polymorphism, Restriction Fragment Length | 1 | 2006 | 763 | 0.020 |
Why?
|
Transcription Factors | 1 | 2005 | 12103 | 0.020 |
Why?
|
Proto-Oncogene Proteins B-raf | 1 | 2015 | 2053 | 0.020 |
Why?
|
Veterinary Medicine | 1 | 2005 | 21 | 0.020 |
Why?
|
Triazoles | 1 | 2011 | 904 | 0.020 |
Why?
|
Age Factors | 2 | 2014 | 18416 | 0.020 |
Why?
|
Forensic Medicine | 1 | 2005 | 64 | 0.020 |
Why?
|
Methods | 1 | 2005 | 1074 | 0.020 |
Why?
|
Cell Separation | 1 | 2011 | 1720 | 0.020 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2013 | 3775 | 0.020 |
Why?
|
Asia | 1 | 2006 | 620 | 0.020 |
Why?
|
Models, Genetic | 1 | 2015 | 3442 | 0.020 |
Why?
|
Seizures | 1 | 2018 | 2917 | 0.020 |
Why?
|
Tuberculosis | 1 | 2017 | 2001 | 0.020 |
Why?
|
Cell Adhesion Molecules | 1 | 2011 | 1602 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2015 | 6544 | 0.010 |
Why?
|
Immunologic Deficiency Syndromes | 1 | 2008 | 557 | 0.010 |
Why?
|
Haplotypes | 1 | 2011 | 2764 | 0.010 |
Why?
|
Codon | 1 | 2006 | 602 | 0.010 |
Why?
|
Sequence Analysis, DNA | 2 | 2011 | 4713 | 0.010 |
Why?
|
Catheterization, Central Venous | 1 | 2009 | 526 | 0.010 |
Why?
|
Child Mortality | 1 | 2007 | 205 | 0.010 |
Why?
|
Antitubercular Agents | 1 | 2013 | 1373 | 0.010 |
Why?
|
Chromosomes, Human, Pair 3 | 1 | 2005 | 315 | 0.010 |
Why?
|
Antimony Sodium Gluconate | 1 | 2003 | 11 | 0.010 |
Why?
|
Neck Injuries | 1 | 2005 | 160 | 0.010 |
Why?
|
Guideline Adherence | 1 | 2014 | 2283 | 0.010 |
Why?
|
Diabetes Insipidus | 1 | 2004 | 144 | 0.010 |
Why?
|
Statistics, Nonparametric | 1 | 2009 | 2852 | 0.010 |
Why?
|
Protein Binding | 1 | 2016 | 9335 | 0.010 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2016 | 3616 | 0.010 |
Why?
|
Prednisone | 1 | 2008 | 1565 | 0.010 |
Why?
|
Endothelial Cells | 1 | 2016 | 3539 | 0.010 |
Why?
|
Injections, Subcutaneous | 1 | 2005 | 680 | 0.010 |
Why?
|
Intestinal Mucosa | 1 | 2014 | 3022 | 0.010 |
Why?
|
Blood Glucose | 1 | 2018 | 6381 | 0.010 |
Why?
|
Antiprotozoal Agents | 1 | 2003 | 94 | 0.010 |
Why?
|
Microphthalmia-Associated Transcription Factor | 1 | 2005 | 259 | 0.010 |
Why?
|
Chorioamnionitis | 1 | 2004 | 156 | 0.010 |
Why?
|
Virus Replication | 1 | 2011 | 2432 | 0.010 |
Why?
|
Liver | 2 | 2011 | 7509 | 0.010 |
Why?
|
Odds Ratio | 1 | 2015 | 9716 | 0.010 |
Why?
|
Pesticides | 1 | 2005 | 293 | 0.010 |
Why?
|
Survival Analysis | 1 | 2015 | 10182 | 0.010 |
Why?
|
Pediatrics | 1 | 2018 | 3586 | 0.010 |
Why?
|
Sequence Alignment | 1 | 2006 | 2176 | 0.010 |
Why?
|
Antiviral Agents | 1 | 2014 | 3061 | 0.010 |
Why?
|
Duodenum | 1 | 2005 | 486 | 0.010 |
Why?
|
Disease Progression | 2 | 2012 | 13502 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2015 | 12159 | 0.010 |
Why?
|
Infant, Low Birth Weight | 1 | 2006 | 859 | 0.010 |
Why?
|
Gene Frequency | 1 | 2008 | 3615 | 0.010 |
Why?
|
Drug Therapy, Combination | 1 | 2012 | 6498 | 0.010 |
Why?
|
Genetic Association Studies | 1 | 2011 | 2717 | 0.010 |
Why?
|
DNA Methylation | 1 | 2015 | 4373 | 0.010 |
Why?
|
Antineoplastic Agents | 1 | 2024 | 13630 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2016 | 18957 | 0.010 |
Why?
|
Amino Acid Sequence | 2 | 2006 | 13451 | 0.010 |
Why?
|
Travel | 1 | 2006 | 785 | 0.010 |
Why?
|
Logistic Models | 1 | 2015 | 13314 | 0.010 |
Why?
|
Sex Distribution | 1 | 2005 | 2295 | 0.010 |
Why?
|
Health Promotion | 1 | 2012 | 2206 | 0.010 |
Why?
|
Lymphocyte Activation | 1 | 2011 | 5496 | 0.010 |
Why?
|
Databases, Factual | 1 | 2015 | 8035 | 0.010 |
Why?
|
Ultrasonography | 1 | 2013 | 5961 | 0.010 |
Why?
|
Molecular Sequence Data | 2 | 2006 | 17624 | 0.010 |
Why?
|
Age Distribution | 1 | 2005 | 2893 | 0.010 |
Why?
|
Wounds, Gunshot | 1 | 2005 | 581 | 0.010 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2005 | 2506 | 0.010 |
Why?
|
Anti-Inflammatory Agents | 1 | 2008 | 1796 | 0.010 |
Why?
|
Pyrimidines | 1 | 2011 | 3016 | 0.010 |
Why?
|
Delivery, Obstetric | 1 | 2005 | 932 | 0.010 |
Why?
|
Immunoglobulin G | 1 | 2009 | 4541 | 0.010 |
Why?
|
Benzenaminium, 4,4'-(3-oxo-1,5-pentanediyl)bis(N,N-dimethyl-N-2-propenyl-), Dibromide | 1 | 1997 | 1 | 0.010 |
Why?
|
Tetraisopropylpyrophosphamide | 1 | 1997 | 2 | 0.010 |
Why?
|
Liver Neoplasms | 1 | 2013 | 4319 | 0.010 |
Why?
|
Phenotype | 1 | 2015 | 16546 | 0.010 |
Why?
|
Models, Biological | 1 | 2013 | 9467 | 0.010 |
Why?
|
Physostigmine | 1 | 1997 | 50 | 0.010 |
Why?
|
Intestines | 1 | 2006 | 1907 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2011 | 14372 | 0.010 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2012 | 4024 | 0.010 |
Why?
|
Mothers | 1 | 2006 | 2186 | 0.010 |
Why?
|
Pregnancy Outcome | 1 | 2006 | 2907 | 0.010 |
Why?
|
Cholinesterase Inhibitors | 1 | 1997 | 238 | 0.010 |
Why?
|
Cell Survival | 1 | 2005 | 5797 | 0.010 |
Why?
|
Anti-Bacterial Agents | 1 | 2013 | 7408 | 0.010 |
Why?
|
Esophagoscopy | 1 | 1994 | 390 | 0.010 |
Why?
|
Survival Rate | 1 | 2007 | 12808 | 0.010 |
Why?
|
Surgical Instruments | 1 | 1994 | 385 | 0.010 |
Why?
|
Mucous Membrane | 1 | 1994 | 657 | 0.010 |
Why?
|
Kidney | 1 | 2006 | 7064 | 0.010 |
Why?
|
Cerebral Cortex | 1 | 2006 | 5761 | 0.010 |
Why?
|
Genome-Wide Association Study | 1 | 2008 | 12626 | 0.010 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2005 | 8515 | 0.010 |
Why?
|
Kinetics | 1 | 1997 | 6377 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2005 | 16939 | 0.000 |
Why?
|
Binding Sites | 1 | 1997 | 6048 | 0.000 |
Why?
|
Base Sequence | 1 | 1997 | 12446 | 0.000 |
Why?
|
Acute Disease | 1 | 1994 | 7269 | 0.000 |
Why?
|